Summit Therapeutics Files 8-K
Ticker: SMMT · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1599298
| Field | Detail |
|---|---|
| Company | Summit Therapeutics Inc. (SMMT) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing
TL;DR
Summit Therapeutics filed an 8-K on 4/25/25. Routine update.
AI Summary
Summit Therapeutics Inc. filed an 8-K on April 25, 2025, reporting other events and financial statements. The company, formerly known as Summit Therapeutics plc and Summit Corp plc, is incorporated in Delaware and headquartered in Miami, Florida.
Why It Matters
This filing indicates routine corporate reporting, providing updates on company events and financial disclosures to the SEC.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for corporate events and financial statements, not indicating any immediate material changes or risks.
Key Players & Entities
- Summit Therapeutics Inc. (company) — Registrant
- Summit Therapeutics plc (company) — Former company name
- Summit Corp plc (company) — Former company name
- April 25, 2025 (date) — Date of report
- Miami, FL (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of April 25, 2025.
When was Summit Therapeutics Inc. incorporated?
Summit Therapeutics Inc. was incorporated in Delaware.
What is the IRS Employer Identification Number for Summit Therapeutics Inc.?
The IRS Employer Identification Number for Summit Therapeutics Inc. is 37-1979717.
What are the former names of Summit Therapeutics Inc.?
The former names of Summit Therapeutics Inc. include Summit Therapeutics plc and Summit Corp plc.
Where are Summit Therapeutics Inc.'s principal executive offices located?
Summit Therapeutics Inc.'s principal executive offices are located at 601 Brickell Key Drive, Suite 1000, Miami, FL 33131.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding Summit Therapeutics Inc. (SMMT).